£13.47m
+369%vs Mar 2024Active11824812Private limited companyLondon
EPOCH BIODESIGN LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Epoch Biodesign Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
EPOCH BIODESIGN LTD is an active private limited company (company number 11824812) incorporated on 13 February 2019, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of £13.47m and cash of £11.57m, with 27 employees on average. Net assets rose 369% on the prior period (£2.88m).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
No active person with significant control is registered.
- Mr Jacob Leon Nathan
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Douglas Bruce Kell
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 13 February 20197 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 27 February 2027in 127 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£11.57m
+469%vs Mar 2024Not reported
27
+8%vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £13.47m | £11.57m | £1.60m | £468k | — | — | 27 |
| 31 March 2024 | £2.88m | £2.04m | £1.12m | £311k | — | — | 25 |
Current ratio28.18Current assets ÷ creditors within one year
Cash per employee£429kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £13,474,994 at 31 March 2025
- Net assets up 10% or more on the prior period+368.7% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 28.18
- Cash at bank of £50,000 or moreCash £11,571,182
- Incorporated five or more years agoIncorporated 13 February 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 127 days
- Next accounts duein 69 days
- Accounts period endNet assets £13.47m · small accounts
- Accounts period endNet assets £2.88m · small accounts
- Incorporated
08
Similar companies in London
09
Reminders for EPOCH BIODESIGN LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.